The goal of this study is to develop a safe, non-invasive method of assessing exocrine pancreatic function as an alternative to the secretin-cholecystokinin stimulation test by evaluating intestinal lipolytic activity. An artificial triglyceride analogue containing para-aminobenzoic acid (DiPalm GMPA) will be administered and blood drawn for serum PABA levels and creatinine. Urine creatine will also be measured.
Showing the most recent 10 out of 426 publications